Skip to main content
Clinical Trials/NL-OMON47512
NL-OMON47512
Completed
Not Applicable

Prediction of illness course and outcome in patients with a first episode of psychosis - Prediction of prognosis after a first psychotic episode

niversitair Medisch Centrum Utrecht0 sites86 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitair Medisch Centrum Utrecht
Enrollment
86
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Eligibility Criteria

Inclusion Criteria

  • \*16\-40 years old
  • \*Written informed consent of subjects aged 18 to 40 years
  • \*Written informed consent of parents and/or legal guardians for subjects aged 16 or 17, in addition to assent from the minor subject, following local laws and regualtions.
  • \*First episode of psychosis as defined by a DSM\-IV diagnosis of schizophrenia or schizophreniform disorder or schizoaffective disorder (depressive type) on the basis of the Structured Clinical Interview for DSM\-IV (SCID\-I) (First et al., 2002\).

Exclusion Criteria

  • \*A time interval between the onset of psychosis and study entry exceeding three years. Onset of psychosis is defined as the first contact with a healthcare professional during which the diagnosis \*psychotic disorder\* is set.
  • \*Any previous neurosurgery or neurological disorder, including epilepsy
  • \*History of head injury resulting in unconsciousness lasting at least 1 hour
  • \*Pregnancy
  • \*Any contraindications for MRI
  • \*Refusing to have their blood drawn and/or their MRI performed
  • \*Incompetency to fully comprehend the purpose of the study or to make a rational decision whether or not to participate

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Predicting Outcome and Disease Course in acquired demyelinating syndromes in childhoodMultiple Sclerosis10012303
NL-OMON55633Erasmus MC, Universitair Medisch Centrum Rotterdam1,200
Not yet recruiting
Not Applicable
Prediction of survival by physicians and assessment of symptoms in patients with liver, pancreatic and gallbladder cancers in a palliative care setting
CTRI/2022/08/044932Tata Memorial Hospital
Completed
Not Applicable
Clinical Outcomes and Prognostic Factors to Predict Treatment Response in High Risk Neuroblastoma Patients Receiving Topotecan and Cyclophosphamide Containing Induction Regimen: A Prospective Multicenter StudyThe study is an observational study and aims to evaluate the clinical outcomes and classify relevant prognostic factors to measure induction response among high risk neuroblastoma patients in Thailandhigh risked neuroblastoma&#44topotecan&#44induction therapy&#44treatment response&#44prognostic factor&#44treatment&#45related toxicity
TCTR20190602002Phramongkutklao Hospital and College of Medicine107
Not yet recruiting
Not Applicable
Predictors of clinical outcomes in patients admitted with influenza and whether troponin levels during hospital admission predicts clinical outcomes in patients with influenza?
ACTRN12618000451202Flinders Medical Centre500
Recruiting
Not Applicable
Retrospective study about the prognosis in patients with non-valvular atrial fibrillation who underwent a percutaneous left atrial appendage closure.onvalvular atrial fibrillation
JPRN-UMIN000045447Department of Cardiology, Kokura Memorial Hospital100